TCT-643 Antiplatelet therapy with cangrelor in patients undergoing surgery after coronary stent implantation: a real-world bridging protocol experience

Perioperative management of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention(PCI) in patients at high thrombotic risk undergoing non- deferrablesurgery remains poorly defined. Cangrelorrepresents a potential bridging treatment option. However, there is limited data in this